Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

AIM/NCYT stock hub

AIM/NCYT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/NCYTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

33.7M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/NCYT

In the news

Latest news · AIM/NCYT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-65.8

P25 -54.2P50 2.1P75 13.7

ROIC-194.4

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/NCYT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

GBP

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	234
Employees Change	-3%
Employees Change Percent	-1.27
Enterprise value	GBX 25.1M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Medical Devices
Isin	FR0010397232
Last refreshed	2026-05-10
Market cap	GBX 33.7M
Price	GBX 46.7
Price currency	GBX
Rev Per Employee	85,594.02x
Sector	Healthcare
Sic	2835
Symbol	aim/NCYT
Website	https://www.novacyt.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-67.95%
EV Earnings	-1.09x
EV/FCF	-2.64x
EV/Sales	1.26x
FCF yield	-28.16%
P/B ratio	1.44x
P/S ratio	1.68x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-142.31%
EBITDA Margin	-49.63%
Gross margin	62.98%
Gross Profit	GBX 12.6M
Gross Profit Growth	12.4%
Gross Profit Growth Q	-75.38%
Gross Profit Growth3 Y	-6.5%
Gross Profit Growth5 Y	22.5%
Net Income	GBX -22.9M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-136.53%
Profit Margin	-114.25%
Profit Per Employee	GBX -97,791
ROA	-32.11
Roa5y	-9.49
ROCE	-82.65
ROE	-65.83
Roe5y	-33.66
ROIC	-194.4
Roic5y	-39.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	22.91%
Cagr3y	0.74%
Cagr5y	-35.53%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	2.03x
Revenue Growth Q	-1.81x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	12.85x
Revenue Growth5 Y	6.74x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.36
Assets	GBX 40.3M
Cash	GBX 19.2M
Current Assets	GBX 33.7M
Current Liabilities	GBX 6.7M
Debt	GBX 10.5M
Debt Equity	GBX 0.45
Debt FCF	GBX -1.1
Equity	GBX 23.4M
Interest Coverage	-6.91
Liabilities	GBX 17M
Long Term Assets	GBX 6.6M
Long Term Liabilities	GBX 10.3M
Net Cash	GBX 8.7M
Net Cash By Market Cap	GBX 25.86
Net Cash Growth	-35.52%
Net Debt Equity	GBX -0.37
Tangible Book Value	GBX 19.8M
Tangible Book Value Per Share	GBX 0.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.75
Inventory Turnover	3.09
Net Working Capital	GBX 3.6M
Quick ratio	4.15
Working Capital	GBX 21.9M
Working Capital Turnover	GBX 0.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	22.9%
200-day SMA	37.02
3Y total return	2.24%
50-day SMA	32.98
50-day SMA vs 200-day SMA	50under200
5Y total return	-88.86%
All Time High	1,270
All Time High Change	-96.32%
All Time High Date	2020-10-26
All Time Low	6.03
All Time Low Change	674.46%
All Time Low Date	2019-10-14
ATR	4.61
Ch YTD	31.74
High	65.2
High52	65.2
High52 Date	2026-05-08
High52ch	-28.37%
Low	43.1
Low52	26.6
Low52 Date	2026-05-05
Low52ch	75.56%
Ma50ch	41.61%
Price vs 200-day SMA	26.15%
RSI	76.18
RSI Monthly	47.67
RSI Weekly	64.62
Sharpe ratio	0.48x
Sortino ratio	1.21
Total Return	-1.25%
Tr YTD	31.74
Tr1m	43.25%
Tr1w	75.56%
Tr3m	35.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -28.5M
Operating margin	-142.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	72,242,174%
Net Borrowing	-1,936,000
Shares Insiders	0.3%
Shares Institutions	0.02%
Shares Yo Y	1.25%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -9.8M
Average Volume	312,966.05x
Bv Per Share	0.32
CAPEX	GBX -268,000
Ch1m	43.25
Ch1w	75.56
Ch1y	22.9
Ch3m	35.56
Ch3y	2.24
Ch5y	-88.86
Ch6m	17.78
Change	10.4%
Change From Open	7.36
Close	42.3
Days Gap	2.84
Depreciation Amortization	18,564,000
Dollar Volume	185,527,705.2
Earnings Date	2026-04-30
EBIT	GBX -28.5M
EBITDA	GBX -9.9M
EPS	GBX -0.32
F Score	3
FCF	GBX -9.5M
FCF EV Yield	-37.85x
Financing CF	-1,953,000
Fiscal Year End	December
Founded	2,006
Goodwill	2,730,000
Income Tax	GBX -3.9M
Investing CF	-181,000
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2025-06-30
Ma150	35.98
Ma150ch	29.79%
Ma20	32.53
Ma20ch	43.57%
Net CF	-11,304,000
Next Earnings Date	2026-06-26
Open	43.5
Position In Range	16.29
Ppne	9,970,000
Price Date	2026-05-08
Ptbv Ratio	1.7
Relative Volume	15.99x
Revenue	20,029,000x
SBC By Revenue	1.69x
Share Based Comp	339,000
Tax By Revenue	-19.44x
Tr6m	17.78%
Volume	3,972,756

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/NCYT pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/NCYT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/NCYT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.0%

Share of float held by funds and institutions

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.3%

Negative means the company is buying back shares.

Technical

AIM/NCYT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

76.2

Above 70: short-term overbought

Price vs 200-day MA

+26.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.48

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/NCYT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/NCYT stock rating?

aim/NCYT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/NCYT analysis?

The full report lives at /stocks/aim/NCYT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/NCYT?

The latest report frames aim/NCYT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/NCYT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.